Ponazuril Capsule
Ponazuril is a formulation containing the antiprotozoal ponazuril, for veterinary use in horses. Available by prescription.
Use as directed by your veterinarian.
Veterinarians most commonly consider ponazuril when a horse is presented with clinical signs associated with Equine Protozoal Myeloencephalitis (EPM). It is also frequently discussed in small animal practice for the management of coccidiosis or other protozoal challenges where targeted intervention is a clinical objective. By addressing the replication of specific protozoal organisms, your veterinarian can manage the parasitic landscape within the patient’s central nervous system or gastrointestinal tract.
At a pharmacological level, ponazuril acts by targeting the apicoplast—a specialized organelle found in certain protozoa, such as Sarcocystis neurona. It interferes with the parasite's ability to maintain essential metabolic functions, inhibiting its replication and survival within the host. Because ponazuril is characterized by its ability to cross the blood-brain barrier, it is a frequent point of clinical focus for neurological conditions triggered by protozoal organisms. Your veterinarian will determine whether ponazuril is appropriate for your pet based on weight, species and specific diagnostic findings.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects of ponazuril administration include mild gastrointestinal changes, such as loose stools or a temporary decrease in appetite. In horses, some owners have observed localized skin irritation, hives or a slight change in coordination shortly after administration. In small animals, transient lethargy or vomiting may occur. Your veterinarian will monitor for these responses and may recommend regular clinical assessments during the course of the prescription.This medication is typically used with caution in patients with known liver or kidney impairment, as these organs are involved in the metabolic processing and elimination of the medication. It is also carefully evaluated in pregnant or lactating animals, as the safety profile for developing offspring has not been fully characterized in every species. Before starting a protocol involving ponazuril, ensure your veterinarian has a complete history of all other supplements and medications your pet is receiving. Contact your veterinarian promptly if you observe significant behavioral shifts, persistent diarrhea or signs of an allergic reaction during the administration period.
Yes. Ponazuril is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all prescriptions before any medication is prepared or sent to your home or stable.
Yes. While ponazuril is available in commercial paste formats for horses, Mixlab can compound this medication into specialized strengths or flavored dosage forms—such as oral liquids or treats—if your veterinarian determines a customized preparation better suits an individual patient's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians discuss ponazuril for neurological concerns because it is used to reach the central nervous system and address the parasites responsible for Equine Protozoal Myeloencephalitis (EPM). Its ability to cross the blood-brain barrier makes it a primary consideration for managing the protozoal organisms that target brain and spinal tissues.
Owners should monitor for signs of gastrointestinal upset, such as loose stools, vomiting or a decrease in appetite. You should also observe your pet's general energy levels and report any persistent lethargy or unusual behavior to your veterinarian to ensure the management approach remains appropriate.
